Best practice calls for discharge planning upon hospital admission. 2 It is clear from the start of the consultation that the patient would not be returning home on the same outpatient ...

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type 2 diabetes. About 99% of AI-based insulin recommendations were adopted by ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine ...

Insulin resistance is a growing health concern worldwide, linked to a variety of conditions such as type 2 diabetes, polycystic ovary syndrome (PCOS), Alzheimer's disease, metabolic syndrome, and ...

"Building on Lilly's legacy of innovation in insulin therapy, once-weekly efsitora may offer a significant advancement for people with type 2 diabetes who need insulin by eliminating over 300 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Insulin efsitora was noninferior to once-daily insulins ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 2 diabetes saw improved HbA1c and time ...

An artificial intelligence (AI) tool was just as good as senior endocrinologists at titrating insulin in the hospital, a Chinese randomized trial found. Among 149 hospitalized patients with type 2 ...

The patient reported a sedentary lifestyle due to chronic back pain that limited activity of daily living and exercise. He consumed two meals daily, usually breakfast and dinner, without snacks in ...